肝动脉插管化疗治疗原发性肝癌

HEPATIC ARTERIAL CHEMOTHERAPY IN THE MANAGEMENT OF PRIMARY LIVER CANCER

我院于1964年4月至1986年12月间,以肝动脉插管化疗为主治疗原发性肝癌87例,随访至1988年12月,全部病例均已死去。治疗后半年和1年生存率分别为25.28％和9.19％。肝大程度、血清硷性磷酸酶、组织学分类和有无肝硬变是影响半年生存率的最重要因素。本文还结合文献进行了简要的讨论。

From April 1964 to Dec. 1986 eighty, seven patients with unresectable primary liver cancer underwent hepatic arterial chemotherapy at our hospital. All patien were followed up until Dec. 1988. All of them died of the disease.1/2-and one-year survival rates were 25.28%and 9.19%,respectively. The degree of hepatomegalia, level of serum alkaline phosphatase, histological typing and the presence of hepatic cirrhosis were the most important factors influencing the prognosis. A brief discussion was made with literature review.